Breaking News

CanSino Biologics Gets OGYÉI GMP Certificate for COVID Vax

Convidecia has been approved in China, Mexico, Pakistan, Hungary and Chile.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

CanSino Biologics Recombinant Novel Coronavirus Vaccine, (Adenovirus Type 5 Vector, trade name Convidecia), has been granted a Good Manufacturing Practice certificate by the Hungarian National Institute of Pharmacy and Nutrition (OGYÉI). The certification was issued on May 21, 2021 after a thorough inspection of CanSinoBIO’s production of Convidecia™.   The GMP certificate recognizes that CanSinoBIO’s manufacturing facilities and quality control system comply with production standa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters